2024-02-01 2025-01-31 false Capium Accounts Production 1.1 11147805 2024-02-01 2025-01-31 11147805 bus:FullAccounts 2024-02-01 2025-01-31 11147805 bus:FRS102 2024-02-01 2025-01-31 11147805 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 11147805 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 11147805 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 11147805 2024-02-01 2025-01-31 11147805 2025-01-31 11147805 bus:RegisteredOffice 2024-02-01 2025-01-31 11147805 core:WithinOneYear 2025-01-31 11147805 core:AfterOneYear 2025-01-31 11147805 1 2024-02-01 2025-01-31 11147805 bus:Director1 2024-02-01 2025-01-31 11147805 bus:Director1 2025-01-31 11147805 bus:Director1 2023-02-01 2024-01-31 11147805 bus:Director2 2024-02-01 2025-01-31 11147805 bus:Director2 2025-01-31 11147805 bus:Director2 2023-02-01 2024-01-31 11147805 bus:Director3 2024-02-01 2025-01-31 11147805 bus:Director3 2025-01-31 11147805 bus:Director3 2023-02-01 2024-01-31 11147805 2023-02-01 11147805 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 11147805 2023-02-01 2024-01-31 11147805 2024-01-31 11147805 core:WithinOneYear 2024-01-31 11147805 core:AfterOneYear 2024-01-31 11147805 bus:EntityAccountantsOrAuditors 2023-02-01 2024-01-31 11147805 core:MotorCars 2024-02-01 2025-01-31 11147805 core:MotorCars 2025-01-31 11147805 core:MotorCars 2024-01-31 11147805 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 11147805 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-01-31 11147805 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 11147805 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 11147805 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 11147805 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 11147805 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 11147805 core:Non-currentFinancialInstruments 2025-01-31 11147805 core:Non-currentFinancialInstruments 2024-01-31 11147805 core:RetainedEarningsAccumulatedLosses 2025-01-31 11147805 core:RetainedEarningsAccumulatedLosses 2024-01-31 11147805 core:RetainedEarningsAccumulatedLosses 2024-02-01 11147805 core:RetainedEarningsAccumulatedLosses 2023-02-01 11147805 core:RetainedEarningsAccumulatedLosses 2024-02-01 2025-01-31 11147805 core:RetainedEarningsAccumulatedLosses 2023-02-01 2024-01-31 11147805 core:RetainedEarningsAccumulatedLosses 2025-01-31 11147805 core:RetainedEarningsAccumulatedLosses 2024-01-31 11147805 dpl:Item1 2024-02-01 11147805 dpl:Item1 2025-01-31 11147805 dpl:Item1 2023-02-01 11147805 dpl:Item1 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11147805
England and Wales

 

 

 

ONTIME RESPONSE HEALTHCARE LIMITED


Unaudited Financial Statements
 


Period of accounts

Start date: 01 February 2024

End date: 31 January 2025
Directors Caroline SIMENDE
Solomon SIMENDE
Simende Caroline
Registered Number 11147805
Registered Office 3 DEMPSTER COURT, BROOKLANDS MILTON KEYNES
MK10 7HP
Accountants Anen Group Limited
8 Tayberry Way
Whittlesey
Peterborough
PE7 2GH
1
Director's report and financial statements
The directors present his/her/their annual report and the financial statements for the year ended 31 January 2025.
Principal activities
Principal activity of the company during the financial year was of healthcare services
Directors
The directors who served the company throughout the year were as follows:
Caroline SIMENDE
Solomon SIMENDE
Simende Caroline
Statement of directors' responsibilities
The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

This report was approved by the board and signed on its behalf by:


----------------------------------
Solomon SIMENDE
Director

Date approved: 08 April 2025
2
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ontime Response Healthcare Limited for the period ended 31 January 2025 which comprise the Profit and loss account, Balance sheet and the notes to the financial statements from the companys accounting records and from information and explanations you have given us.

This report is made solely to the Director of Ontime Response Healthcare Limited, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Ontime Response Healthcare Limited and state those matters that we have agreed to state to them in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ontime Response Healthcare Limited and its Director for our work, or for this report.

It is your duty to ensure that Ontime Response Healthcare Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and
profit of Ontime Response Healthcare Limited. You consider that Ontime Response Healthcare Limited is exempt from the statutory audit requirement for the period.
We have not been instructed to carry out an audit or a review of the accounts of Ontime Response Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.



....................................................

Anen Group Limited

8 Tayberry Way
Whittlesey
Peterborough
PE7 2GH
08 April 2025
3
 
 
Notes
 
2025
£
  2024
£
Turnover 752,319    410,750 
Gross profit 752,319    410,750 
Administrative expenses (664,239)   (339,499)
Other operating income 1,500   
Operating profit 89,580    71,251 
Profit/(Loss) on ordinary activities before taxation 89,580    71,251 
Tax on profit on ordinary activities (17,020)   (11,095)
Profit/(Loss) for the financial year 72,560    60,156 
 
4
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 4,800    4,000 
4,800    4,000 
Current assets      
Debtors 4 71,139    64,301 
Cash at bank and in hand 251,454    71,283 
322,593    135,584 
Creditors: amount falling due within one year 5 (108,425)   (11,095)
Net current assets 214,168    124,489 
 
Total assets less current liabilities 218,968    128,489 
Creditors: amount falling due after more than one year 6 (83,536)   (80,000)
Net assets 135,432    48,489 
 

Capital and reserves
     
Profit and loss account 135,432    48,489 
Shareholders' funds 135,432    48,489 
 


For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 08 April 2025 and were signed on its behalf by:


-------------------------------
Solomon SIMENDE
Director
5
  Retained Earnings   Total
£ £
At 01 February 2023 (11,667) (11,667)
Profit for the year 60,156  60,156 
Total comprehensive income for the year 60,156  60,156 
Total investments by and distributions to owners
At 31 January 2024 48,489  48,489 
At 01 February 2024 68,872  68,872 
Profit for the year 72,560  72,560 
Total comprehensive income for the year 72,560  72,560 
Dividends (6,000) (6,000)
Total investments by and distributions to owners (6,000) (6,000)
At 31 January 2025 135,432  135,432 
6
General Information
ONTIME RESPONSE HEALTHCARE LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11147805, registration address 3 DEMPSTER COURT, BROOKLANDS MILTON KEYNES , MK10 7HP.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2.

Average number of employees


Average number of employees during the year was 17 (2024 : 12).
3.

Tangible fixed assets

Cost or valuation Motor Vehicles   Total
  £   £
At 01 February 2024 4,000    4,000 
Additions 3,500    3,500 
Disposals  
At 31 January 2025 7,500    7,500 
Depreciation
At 01 February 2024 1,000    1,000 
Charge for year 1,700    1,700 
On disposals  
At 31 January 2025 2,700    2,700 
Net book values
Closing balance as at 31 January 2025 4,800    4,800 
Opening balance as at 01 February 2024 4,000    4,000 


4.

Debtors: amounts falling due within one year

2025
£
  2024
£
Trade Debtors 54,496    64,301 
Accrued Income 9,731   
64,227    64,301 

4.

Debtors: amounts falling due after one year

2025
£
  2024
£
Directors Loan Accounts 6,912   
6,912   

5.

Creditors: amount falling due within one year

2025
£
  2024
£
Corporation Tax 17,020    11,095 
Accrued Expenses 60,157   
Other Creditors 31,248   
108,425    11,095 

6.

Creditors: amount falling due after more than one year

2025
£
  2024
£
Bank Loans & Overdrafts 18,817    20,000 
Other Creditors 64,719    60,000 
83,536    80,000 

7